BEIJING, April 26 (CGTN) - China's National Medical Products Administration on Tuesday approved Sinopharm's COVID-19 vaccine specified for Omicron variant for clinical trials.
China approves clinical trials of Sinopharm's Omicron-specific vaccine
- Hits: 2136
